InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: flipper44 post# 178538

Monday, 06/18/2018 7:02:08 PM

Monday, June 18, 2018 7:02:08 PM

Post# of 700693
Flipper44,

Linda Powers keeps repeating that all data remain blinded at the present. I think that means the last 32 patients included.

Quote:
“The data is to be viewed as preliminary for the time being,” explains Linda Power, CEO of the company behind the drug, Northwest Biotherapeutics, Inc. “The study is still ongoing and all of the data remain blinded at present.”

https://www.izi.fraunhofer.de/en/press/press-releases/manufacturing-immunotherapeutics-for-the-treatment-of-brain-tumors.html

Quote:
“The trial is ongoing while the data continue to mature, and the Company, the investigators and patients all remain blinded.”

https://www.nwbio.com/nwbio-announces-scientific-publication-interim-survival-data-phase-3-trial-dcvax-l-glioblastoma-brain-cancer/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News